ProPharma Group Acquires Pharmica Consulting

Odyssey Investment Partners Acquires ProPharma Group

September 22, 2020

Healthcare Services

Odyssey Investment Partners has agreed to acquire ProPharma Group from Linden Capital Partners. ProPharma Group, a global provider of regulatory, compliance, pharmacovigilance and medical information services headquartered in Overland Park, Kansas, will be led by CEO Dawn Sherman and the existing management team who are reinvesting alongside Odyssey to pursue organic and inorganic growth.

ProPharma Group Acquires Diamond Pharma Services

March 2, 2021

Healthcare Services

ProPharma Group, a portfolio company of Odyssey Investment Partners, has acquired Diamond Pharma Services, a UK-based regulatory affairs, pharmacovigilance, and compliance consultancy. The deal expands ProPharma's global regulatory and pharmacovigilance capabilities and adds Diamond's ~85+ experts and UK footprint to ProPharma's existing suite of services.

ProPharma Group Acquires The Planet Group

May 27, 2021

Staffing & HR

ProPharma Group, a portfolio company of Odyssey Investment Partners, has reached an agreement to merge with/acquire The Planet Group. MidOcean Partners sold its majority stake in The Planet Group as part of the transaction; the combined company will expand ProPharma's global footprint and human capital services, creating a business with over 1,900 colleagues worldwide.

ProPharma Group Acquires Kateric

September 1, 2022

Healthcare Services

ProPharma Group, an Odyssey Investment Partners–backed provider of regulatory, clinical, and compliance services, has acquired Kateric, a medical writing firm founded in 2004. The deal expands ProPharma's medical writing capabilities and brings Kateric's leadership and global writing resources into ProPharma's portfolio.

ProPharma Group Acquires iSafety Systems

August 10, 2021

Healthcare Services

ProPharma Group, a portfolio company of Odyssey Investment Partners, has acquired Hyderabad-based iSafety Systems, a provider of end-to-end pharmacovigilance and safety solutions. The add-on expands ProPharma’s global pharmacovigilance capacity and regulatory/compliance capabilities, strengthening service coverage across 130+ countries.

ProPharma Group Acquires M Squared Associates

March 16, 2022

Healthcare Services

ProPharma Group, a portfolio company of Odyssey Investment Partners, has acquired M Squared Associates, a clinical, regulatory and quality consulting firm serving the medical device and diagnostic industry. The acquisition expands ProPharma's med‑tech capabilities across clinical affairs, regulatory strategy and quality systems, enabling broader end‑to‑end support for device, combination product and diagnostic clients globally.